Drugs / Saccharomyces boulardii CNCM I-745
Saccharomyces boulardii CNCM I-745
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT07168434 | Oct 2025 → Oct 2026 expected | functional diarrhea, irritable bowel syndrome | Biocodex | Recruiting | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT06451913 | Jul 2025 → Dec 2026 expected | — | Biocodex | Recruiting | No outcome recorded |
| Phase 4 | NCT07371819 | Jan 2019 → Jan 2026 overdue | acute diarrhea | Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan | Active not recruiting | No outcome recorded |
| Phase 4 | NCT04786938 | Apr 2016 → Jun 2017 | — | Universidad San Francisco de Quito | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saccharomyces boulardii CNCM-I-745 | “The main objective of the research is to demonstrate the efficacy of Saccharomyces boulardii CNCM I-745 on global IBS symptoms, measured by the Irritable Bowel Syndrome Symptom...” NCT07168434 ↗4“The study is designed to compare the efficacy of Saccharomyces boulardii CNCM-I-745 500 mg bid to a placebo in patients undergoing antibiotic therapy in the context of erythema...” NCT06451913 ↗ “Saccharomyces boulardii CNCM I-745 is a probiotic with demonstrated efficacy in children with acute diarrhea; however, evidence regarding its use in bloody diarrhea (BD) is lacking.” NCT07371819 ↗ “Saccharomyces boulardii CNCM I-745 (Sb) can improve dysbiosis and reduce the abundance of multi-resistant bacteria.” NCT04786938 ↗ |
| Known as | S. boulardii CNCM I-745 | “addition of probiotics, as S. boulardii CNCM I-745 (Sb).” NCT04786938 ↗ |
| Known as | Saccharomyces boulardi (Sb) | “Drug: Saccharomyces Boulardii 250 MG Saccharomyces boulardi (Sb) 250 mg dose to be administered to the patient” NCT07371819 ↗ |
| Modality | Other / unclassified | “Sb is a probiotic yeast” NCT04786938 ↗ |
| Route | Oral | “Oral Dose Form” NCT04786938 ↗ |